TRIM48 Activators is a conceptual group of chemical agents that can modulate the activity of TRIM48 by influencing related cellular pathways and processes. These agents exert their effects on TRIM48 not by direct interaction but by altering the cellular environment or the activity of closely associated pathways. MG132 and Epoxomicin could lead to the accumulation of ubiquitinated proteins, which may stabilize TRIM48 indirectly by saturating the degradation pathways that might otherwise target TRIM48 for degradation.
NF-κB, JNK, p38 MAPK, PI3K, and MEK, can result in changes to cellular signaling networks that indirectly affect the stability and function of TRIM48. For instance, the NF-κB pathway, which can be modulated by compounds like PDTC and BMS-345541, is involved in the regulation of immune and stress response genes, some of which may be co-regulated with TRIM48. Similarly, alterations in the activity of mTOR by rapamycin can have widespread effects on cell growth and autophagy, processes that might influence TRIM48 indirectly. This class of activators encompasses a wide variety of mechanisms, all converging on the upregulation of TRIM48 through indirect means. Each chemical agent listed brings about changes in cellular signaling pathways or homeostasis that create an environment conducive to either the increased expression or stabilization of TRIM48.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
Another proteasome inhibitor, could lead to stabilization of proteins in the ubiquitin-proteasome pathway, affecting TRIM48 levels. | ||||||
BMS-345541 | 445430-58-0 | sc-221741 | 1 mg | $312.00 | 1 | |
Specifically inhibits IκB kinase, altering NF-κB activity, which could affect TRIM48. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Cyclin-dependent kinase inhibitor, could influence cell cycle-related proteins and potentially impact TRIM48. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Modulator of the ubiquitin-proteasome pathway, which could lead to changes in TRIM48 activity. | ||||||